Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia

被引：0
|
作者：
Zachary A. Yetmar
Ryan B. Khodadadi
John Raymond Go
Supavit Chesdachai
Omar M. Abu Saleh
机构：
[1] Mayo Clinic,Division of Public Health, Infectious Diseases, and Occupational Medicine
来源：
European Journal of Clinical Microbiology & Infectious Diseases | 2023年 / 42卷
关键词：
Bloodstream infection; Ceftriaxone; Cefazolin; Oxacillin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia is associated with poor outcomes. Ceftriaxone offers logistical advantages over other standard therapies, though in vitro studies have questioned its efficacy and clinical studies of ceftriaxone in MSSA bacteremia are conflicting.
引用
收藏
页码：423 / 430
页数：7
相关论文
共 50 条
  • [1] Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia
    Yetmar, Zachary A.
    Khodadadi, Ryan B.
    Go, John Raymond
    Chesdachai, Supavit
    Abu Saleh, Omar M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (04) : 423 - 430
  • [2] β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins
    Li, Julius
    Echevarria, Kelly L.
    Traugott, Kristi A.
    PHARMACOTHERAPY, 2017, 37 (03): : 346 - 360
  • [3] Retrospective Evaluation of the Association of Oxacillin MIC on Acute Treatment Outcomes with Cefazolin and Antistaphylococcal Penicillins in Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Hess, Kyle A.
    Kooda, Kirstin
    Shulha, Jennifer A.
    Mara, Kristin
    Go, John R.
    Fida, Madiha
    DeSimone, Daniel C.
    Stevens, Ryan W.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2023, 61 (04) : 1 - 13
  • [4] Ceftriaxone versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia
    Mohamed, Adham
    Bennett, Nicholas
    Ploetz, Jeannette
    Aragon, Laura
    Kennedy, Kevin
    Boyd, Sarah
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (03)
  • [5] Nafcillin versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia
    Monogue, Marguerite L.
    Ortwine, Jessica K.
    Wei, Wenjing
    Eljaaly, Khalid
    Bhavan, Kavita P.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (05) : 727 - 731
  • [6] Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis
    Changcheng Shi
    Yubo Xiao
    Qi Zhang
    Qingyu Li
    Fei Wang
    Jing Wu
    Nengming Lin
    BMC Infectious Diseases, 18
  • [7] Efficacy and safety of cefazolin versus antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteremia: a systematic review and meta-analysis
    Shi, Changcheng
    Xiao, Yubo
    Zhang, Qi
    Li, Qingyu
    Wang, Fei
    Wu, Jing
    Lin, Nengming
    BMC INFECTIOUS DISEASES, 2018, 18
  • [8] Cefazolin therapy for methicillin-susceptible Staphylococcus aureus bacteremia in Japan
    Shoji, Takayo
    Hirai, Yuji
    Osawa, Makiko
    Totsuka, Kyoichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (3-4) : 175 - 180
  • [9] Definitive Treatment for Methicillin-Susceptible Staphylococcus aureus Bacteremia: Data Versus a Definitive Answer?
    Karchmer, Adolf W.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (01) : 107 - 109
  • [10] Is Cefazolin Inferior to Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia?
    Lee, Shinwon
    Choe, Pyoeng Gyun
    Song, Kyoung-Ho
    Park, Sang-Won
    Kim, Hong Bin
    Kim, Nam Joong
    Kim, Eui-Chong
    Park, Wan Beom
    Oh, Myoung-don
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (11) : 5122 - 5126
12345